Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Galapagos ( (GB:0JXZ) ) has provided an announcement.
Galapagos announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference, where it will present its strategic direction and innovations in San Francisco. The event marks an opportunity for Galapagos to engage with analysts and stakeholders, reinforcing its commitment to addressing unmet medical needs and shaping the future of healthcare.
More about Galapagos
Galapagos is a biotechnology company operating in Europe and the U.S., focused on transforming patient outcomes through innovative science. It addresses high unmet medical needs with a pipeline of small molecules and cell therapies in oncology and immunology, utilizing a decentralized cell therapy manufacturing platform.
YTD Price Performance: 4.16%
Average Trading Volume: 6,922
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €1.81B
Find detailed analytics on 0JXZ stock on TipRanks’ Stock Analysis page.
